|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/135 | |
| A61K 31/70 | |||
| A61P 25/00 | |||
| A61K 9/20 |
| (11) | Number of the document | 2506842 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10835166.9 |
| Date of filing the European patent application | 2010-12-03 | |
| (97) | Date of publication of the European application | 2012-10-10 |
| (45) | Date of publication and mention of the grant of the patent | 2015-01-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2010/058831 |
| Date | 2010-12-03 |
| (87) | Number | WO 2011/069032 |
| Date | 2011-06-09 |
| (30) | Number | Date | Country code |
| 266864 P | 2009-12-04 | US |
| (72) |
LAUGHLIN, Sharon, M., US
SIZENSKY, Michael, J., US
SINGH, Surendra, P., US
WILKINSON, Scott, H., US
HUANG, Cai Gu, US
BONASIA, Philip, James, US
D`SOUZA, Susan, S., US
|
| (73) |
Sunovion Pharmaceuticals Inc.,
84 Waterford Drive, Marlborough, MA 01752,
US
|
| (54) | FORMULATIONS, SALTS AND POLYMORPHS OF TRANSNORSERTRALINE AND USES THEREOF |
| FORMULATIONS, SALTS AND POLYMORPHS OF TRANSNORSERTRALINE AND USES THEREOF |